Treace Medical Concepts, Inc. (NASDAQ:TMCI) shares lost ground Friday. The Ponte Verde, Fla.-based company, a medical technology concern driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced that it will release financial results for the third quarter 2026 before the start of trading on Friday, November 6. Company management will host a conference call to discuss financial results beginning at 8:00 am ET.
Treace routinely posts information that may be important to investors in the “Investor Relations” section of its website at www.treace.com. The Company encourages investors and potential investors to consult the
Treace website regularly for important information about Treace.
Treace is a medical technology company with the goal of advancing the standard of care for the surgical management of bunion and related midfoot deformities.
TMCI shares dived 19 cents, or 4.5%. to $4.09.
Related Stories
